CoChat

The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.

Paracetamol: A Review of Guideline Recommendations

Open access

Abstract

Musculoskeletal pain conditions are age-related, leading contributors to chronic pain and pain-related disability, which are expected to rise with the rapid global population aging. Current medical treatments provide only partial relief. Furthermore, non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are effective in young and otherwise healthy individuals but are often contraindicated in elderly and frail patients. As a result of its favorable safety and tolerability record, paracetamol has long been the most common drug for treating pain. Strikingly, recent reports questioned its therapeutic value and safety. This review aims to present guideline recommendations. Paracetamol has been assessed in different conditions and demonstrated therapeutic efficacy on both acute and chronic pain. It is active as a single agent and is additive or synergistic with NSAIDs and opioids, improving their efficacy and safety. However, a lack of significant efficacy and hepatic toxicity have also been reported. Fast dissolving formulations of paracetamol provide superior and more extended pain relief that is similar to intravenous paracetamol. A dose reduction is recommended in patients with liver disease or malnourished. Genotyping may improve efficacy and safety. Within the current trend toward the minimization of opioid analgesia, it is consistently included in multimodal, non-opioid, or opioid-sparing therapies. Paracetamol is being recommended by guidelines as a first or second-line drug for acute pain and chronic pain, especially for patients with limited therapeutic options and for the elderly.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm10153420

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart of study screening, eligibility and inclusion.
Figure 1 Flowchart of study screening, eligibility and inclusion.CC BY · PubMed Central
Figure 2 Molecular structure of paracetamol (acetaminophen).
Figure 2 Molecular structure of paracetamol (acetaminophen).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 154 references

Cited by

See all 208

Metadata

Authors
Freo, U., Ruocco, C., Valerio, A., Scagnol, I., & Nisoli, E.
Affiliations
  • University of Padua (IT)
  • University of Milan (IT)
  • University of Brescia (IT)
Corresponding author
Freo, Ulderico
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2021-07-31
Volume
10
Issue
15
Pages
3420
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3188836359
Cited by
208
References
154
Citations by year
2026: 39 · 2025: 54 · 2024: 43 · 2023: 48 · 2022: 22 · 2021: 2
FWCI
7.17
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, cc-by)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
  • Fondazione Cariplo (2016-1006)
  • Fondazione Umberto Veronesi (2016-1006)
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Keywords
paracetamol, musculoskeletal pain, chronic pain, acute pain, guideline recommendations, NSAID combination therapy, hepatotoxicity, genetic polymorphism, elderly patients, vulnerable patients, multimodal analgesia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Paracetamol: A Review of Guideline Recommendations. https://app.cochat.ai/papers/10.3390/jcm10153420
The paper
Freo, U., Ruocco, C., Valerio, A., Scagnol, I., & Nisoli, E. (2021). Paracetamol: A Review of Guideline Recommendations. Journal of Clinical Medicine. https://doi.org/10.3390/jcm10153420

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.